In vitro thymosin- and levamisole-induced increase of lymphocyte transformation in psoriatic patients.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 742911)

Published in Arch Dermatol Res on December 01, 1978

Authors

J Eskola, E Soppi, O Ruuskanen, J E Fräki

Articles by these authors

Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87

Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24

Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol (2000) 3.02

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83

A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr (2007) 2.82

Diphtheria after visit to Russia. Lancet (1993) 2.74

Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med (1987) 2.47

Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis. J Clin Microbiol (1993) 2.41

The effect of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-81. Lancet (1986) 2.29

Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res (1992) 2.17

Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol (1999) 2.09

Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child (1991) 2.05

Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol (1998) 1.89

Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. BMJ (2001) 1.85

Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun (1998) 1.79

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J Infect Dis (1998) 1.76

Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol (1999) 1.75

Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J Clin Microbiol (1994) 1.71

Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect (2011) 1.70

Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis (1995) 1.65

Signs and symptoms predicting acute otitis media. Arch Pediatr Adolesc Med (1995) 1.64

Identification of enteroviruses in clinical specimens by competitive PCR followed by genetic typing using sequence analysis. J Clin Microbiol (1996) 1.64

Differentiation of bacterial and viral pneumonia in children. Thorax (2002) 1.59

Patient awareness of seizures. Neurology (1996) 1.56

Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae. Clin Exp Immunol (1999) 1.56

Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA). Scand J Infect Dis (1982) 1.56

Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis (2001) 1.55

Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J (2000) 1.50

Health services resources and their relation to mortality from causes amenable to health care intervention: a cross-national study. Int J Epidemiol (1988) 1.50

Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child (1991) 1.49

Circulating myeloperoxidase may cause false negative findings in the analysis of myeloperoxidase antibodies in systemic vasculitis. Scand J Immunol (1994) 1.43

Effect of sport stress on lymphocyte transformation and antibody formation. Clin Exp Immunol (1978) 1.43

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. Vaccine (1999) 1.43

Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. Bone Marrow Transplant (2013) 1.41

Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics (1994) 1.40

Induced sputum in the diagnosis of childhood community-acquired pneumonia. Thorax (2008) 1.39

Intrafamilial spread of pertussis. J Pediatr (1983) 1.39

Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J Immunol (1987) 1.38

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J (1998) 1.37

Measles vaccination after exposure to natural measles. J Pediatr (1978) 1.37

Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36

Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. J Biol Chem (1983) 1.33

Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol (1997) 1.29

Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J Clin Microbiol (1990) 1.29

Immunoassay diagnosis of adenovirus infections in children. J Clin Microbiol (1983) 1.29

Immunoglobulin class-specific antibody response in respiratory syncytial virus infection measured by enzyme immunoassay. J Med Virol (1984) 1.28

Diagnosis of respiratory syncytial virus infection in children: comparison of viral antigen detection and serology. J Med Virol (1984) 1.27

Risk factors for recurrent otitis media. Pediatr Infect Dis (1986) 1.26

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine (1999) 1.24

Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20

The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child (1991) 1.20

Diagnostic findings in 95 Finnish patients with common variable immunodeficiency. J Clin Immunol (2001) 1.19

Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician. Eur J Pediatr (1987) 1.19

Virus shedding after human rhinovirus infection in children, adults and patients with hypogammaglobulinaemia. Clin Microbiol Infect (2013) 1.19

Sinusitis in the common cold. J Allergy Clin Immunol (1998) 1.18

The second Geneva Consensus: Recommendations for novel live TB vaccines. Vaccine (2010) 1.18

Report of a workshop on respiratory viral infections: epidemiology, diagnosis, treatment, and prevention. Clin Infect Dis (1993) 1.18

C-reactive protein in respiratory virus infections. J Pediatr (1985) 1.17

Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis (2000) 1.17

Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics (1998) 1.16

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. J Infect Dis (2001) 1.16

C reactive protein in the evaluation of febrile illness. Arch Dis Child (1986) 1.16

Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J (1995) 1.15

Molecular diagnosis of human rhinovirus infections: comparison with virus isolation. J Clin Microbiol (1998) 1.14

Finnish approach to the treatment of acute otitis media. Report of the Finnish Consensus Conference. Ann Otol Rhinol Laryngol Suppl (1987) 1.13

Diagnosis of pertussis. J Infect (1984) 1.13

Effect of in ovo treatment with cyclophosphamide on lymphoid system in chicken. Cell Immunol (1974) 1.12

Age-dependent variation in the serum concentration of mannan-binding protein. Acta Paediatr (1996) 1.12

Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin. Scand J Immunol (1988) 1.11

A new micromethod for lymphocyte stimulation using whole blood. Immunol Commun (1975) 1.11

Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine (1998) 1.10

Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis J (1995) 1.10

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J (1996) 1.10

Fever in respiratory virus infections. Am J Dis Child (1986) 1.10

Human skin proteases: separation and characterization of two alkaline proteases, one splitting trypsin and the other chymotrypsin substrates. Arch Dermatol Res (1975) 1.10

Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin. Arch Dermatol Res (1988) 1.09

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2001) 1.09

Human skin tryptase: purification, partial characterization and comparison with human lung tryptase. Biochim Biophys Acta (1988) 1.08

Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine (2000) 1.08

Staphylococcus aureus Cowan I-induced immunoglobulin production in human cord blood lymphocytes. J Immunol (1980) 1.08

Antibody reactivity against thyroid peroxidase and myeloperoxidase in autoimmune thyroiditis and systemic vasculitis. Scand J Immunol (1997) 1.07

New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis (1997) 1.07

Issues about pertussis vaccines. Lancet (1998) 1.07

C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06

Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis (1987) 1.06

Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA (1995) 1.06

Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med (1989) 1.06

Bacteremic urinary tract infection in children. Pediatr Infect Dis J (2000) 1.06

Human sweat kallikrein. Biochemical demonstration and chromatographic separation from several other esteropeptidases in the sweat. Acta Derm Venereol (1970) 1.06

Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease. Lancet (1987) 1.05

Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis (1990) 1.05

Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J (1999) 1.05

Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J (1995) 1.05